A seemingly more effective way to fight cancer, and an investment opportunity as well.
The past…
Historically, cancer treatments were generalized, and to this day the same treatment(s) are given to nearly everyone. It’s a process of trial and error. Doctors don’t always know if a selected drug and/or combination of chemotherapy will help a particular patient or harm them.
What if?…
What if there were a way to reduce the uncertainty in this process?
What if there were a way to predict that a drug is unlikely to work, and therefore should not be given, and that another drug is much more likely to work in a particular patient?
According to Dr. Silvana Martino, Director of Breast Cancer Research and Education at The Angeles Clinic Foundation in California, these questions are not new. However, new answers are now available to these questions. Answers that we expect are superior to prior answers.
Click here to quickly become a BMR member and read the rest of this special report on a fast-growing NASDAQ company developing advanced technology solutions and services to personalize cancer drug treatments, or login with your username and password…
